Watts GF - Search Results

1

Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemia.

Chan DC, Watts GF, Barrett PH, Beilin LJ, Redgrave TG, Mori TA. Chan DC, et al. Among authors: watts gf. Diabetes. 2002 Aug;51(8):2377-86. doi: 10.2337/diabetes.51.8.2377. Diabetes. 2002. PMID: 12145148 Clinical Trial.

2

Simvastatin decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: pathophysiological and therapeutic implications.

Watts GF, Cummings MH, Umpleby M, Quiney JR, Naoumova R, Thompson GR, Sönksen PH. Watts GF, et al. Eur J Clin Invest. 1995 Aug;25(8):559-67. doi: 10.1111/j.1365-2362.1995.tb01746.x. Eur J Clin Invest. 1995. PMID: 7589011 Clinical Trial.

3

Exercise testing as a long-term predictor of the development of microalbuminuria in normoalbuminuric IDDM patients.

O'Brien SF, Watts GF, Powrie JK, Shaw KM. O'Brien SF, et al. Among authors: watts gf. Diabetes Care. 1995 Dec;18(12):1602-5. doi: 10.2337/diacare.18.12.1602. Diabetes Care. 1995. PMID: 8722059

4

Lipids, lipoproteins, antioxidants and glomerular and tubular dysfunction in type 1 diabetes.

O'Brien SF, Watts GF, Powrie JK, Shaw KM, Miller NJ. O'Brien SF, et al. Among authors: watts gf. Diabetes Res Clin Pract. 1996 Apr;32(1-2):81-90. doi: 10.1016/0168-8227(96)01252-1. Diabetes Res Clin Pract. 1996. PMID: 8803485

5

Determinants of the kinetics of very low-density lipoprotein apolipoprotein B-100 in non-obese men.

Watts GF, Riches FM, Kelly JM, Powell MA, Croft KD. Watts GF, et al. Clin Exp Pharmacol Physiol. 1997 Aug;24(8):556-62. doi: 10.1111/j.1440-1681.1997.tb02090.x. Clin Exp Pharmacol Physiol. 1997. PMID: 9269527

6

Inhibition of cholesterogenesis decreases hepatic secretion of apoB-100 in normolipidemic subjects.

Watts GF, Naoumova RP, Kelly JM, Riches FM, Croft KD, Thompson GR. Watts GF, et al. Am J Physiol. 1997 Sep;273(3 Pt 1):E462-70. doi: 10.1152/ajpendo.1997.273.3.E462. Am J Physiol. 1997. PMID: 9316434 Clinical Trial.

7

Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity.

Riches FM, Watts GF, Naoumova RP, Kelly JM, Croft KD, Thompson GR. Riches FM, et al. Among authors: watts gf. Int J Obes Relat Metab Disord. 1998 May;22(5):414-23. doi: 10.1038/sj.ijo.0800602. Int J Obes Relat Metab Disord. 1998. PMID: 9622338

8

Apolipoprotein B signal peptide and apolipoprotein E genotypes as determinants of the hepatic secretion of VLDL apoB in obese men.

Riches FM, Watts GF, van Bockxmeer FM, Hua J, Song S, Humphries SE, Talmud PJ. Riches FM, et al. Among authors: watts gf. J Lipid Res. 1998 Sep;39(9):1752-8. J Lipid Res. 1998. PMID: 9741687 Free article.

9

Postprandial dyslipidaemia in a nutshell: food for thought.

Watts GF, Mamo JC, Redgrave TG. Watts GF, et al. Aust N Z J Med. 1998 Dec;28(6):816-23. doi: 10.1111/j.1445-5994.1998.tb01560.x. Aust N Z J Med. 1998. PMID: 9972413 Review. No abstract available.

10

Reduction in visceral adipose tissue is associated with improvement in apolipoprotein B-100 metabolism in obese men.

Riches FM, Watts GF, Hua J, Stewart GR, Naoumova RP, Barrett PH. Riches FM, et al. Among authors: watts gf. J Clin Endocrinol Metab. 1999 Aug;84(8):2854-61. doi: 10.1210/jcem.84.8.5925. J Clin Endocrinol Metab. 1999. PMID: 10443691

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

903 results

Search Page

Filters